Literature DB >> 2427635

Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.

P S Tobias, K Soldau, R J Ulevitch.   

Abstract

This report describes the purification of an acute phase reactant from acute phase rabbit serum, which endows normal serum with the properties of acute phase serum, insofar as LPS is concerned. The acute phase reactant is referred to as LPS-binding protein, or LBP. LBP was purified approximately 2,000-fold by chromatography of acute phase serum on Bio-Rex 70 and Mono-Q resins. The resulting preparation consisted of two glycoproteins having molecular weights of 60,500 and 58,000; the two were obtained in a variable ratio, usually near 10:1, respectively. After separation by SDS-PAGE, the N-terminal 36 amino acid sequences of the two proteins were identical. From the N-terminal sequence, as well as other properties of LBP, LBP appears to be unrelated to any known acute phase reactants. The direct interaction of LPS and LBP was inferred from two types of evidence: first, immunoprecipitation of [3H]LPS from APRS by anti-LBP sera; and second, by the 125I-labeling of LBP when APRS-containing 125I-labeled 2-(p-azidosalicylamido)ethyl 1,3'-dithiopropionyl-LPS was photolysed. The data presented here support the concept that the 60-kD glycoprotein we have termed LBP is a newly recognized acute phase reactant that may modulate the biochemical and biologic properties of LPS in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427635      PMCID: PMC2188379          DOI: 10.1084/jem.164.3.777

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Estimation of 3-deoxy sugars by means of the malonaldehyde-thiobarbituric acid reaction.

Authors:  M A CYNKIN; G ASHWELL
Journal:  Nature       Date:  1960-04-09       Impact factor: 49.962

2.  The preparation and characterization of a radioiodinated bacterial lipopolysaccharide.

Authors:  R J Ulevitch
Journal:  Immunochemistry       Date:  1978-03

3.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

4.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

5.  New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma.

Authors:  R J Ulevitch; A R Johnston; D B Weinstein
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

6.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.

Authors:  J C Mathison; R J Ulevitch
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

7.  Blood endotoxin inactivation after trauma and endotoxicosis.

Authors:  J P Filkins
Journal:  Proc Soc Exp Biol Med       Date:  1976-01

8.  New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides.

Authors:  R J Ulevitch; A R Johnston; D B Weinstein
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

9.  The selective binding of aggregated IgG to lipid A-rich bacterial lipopolysaccharides.

Authors:  M H Ginsberg; D C Morrison
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

10.  The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.

Authors:  R J Ulevitch; A R Johnston
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

View more
  124 in total

1.  Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells.

Authors:  T Gutsmann; M Müller; S F Carroll; R C MacKenzie; A Wiese; U Seydel
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 2.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Involvement of diacylglycerol production in activation of nuclear factor kappaB by a CD14-mediated lipopolysaccharide stimulus.

Authors:  H Yamamoto; K Hanada; M Nishijima
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 4.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

5.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

6.  Lipopolysaccharide-binding protein: localization in secretory granules of Paneth cells in the mouse small intestine.

Authors:  Gert H Hansen; Karina Rasmussen; Lise-Lotte Niels-Christiansen; E Michael Danielsen
Journal:  Histochem Cell Biol       Date:  2009-02-21       Impact factor: 4.304

7.  Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.

Authors:  M Arditi; J Zhou; R Dorio; G W Rong; S M Goyert; K S Kim
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

Authors:  J Pugin; C C Schürer-Maly; D Leturcq; A Moriarty; R J Ulevitch; P S Tobias
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

Review 9.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

10.  Increased lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits.

Authors:  B E Brito; E L Romano; C Grunfeld
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.